首页 / 院系成果 / 成果详情页

Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer  期刊论文  

  • 编号:
    e787a92c-f3dc-43a2-b14a-527628c28e85
  • 作者:
    Wang, Zehua#[1,2]Gao, Jianwen[3,4];Zhou, Jiabing[1,2];Liu, Haiou*[1,2]Xu, Congjian(徐丛剑)*[1,2,5]
  • 语种:
    英文
  • 期刊:
    JOURNAL OF GYNECOLOGIC ONCOLOGY ISSN:2005-0380 2019 年 30 卷 2 期 ; MAR
  • 收录:
  • 关键词:
  • 摘要:

    Objective: Poly (ADP-ribose) polymerase (PARP) is an important molecule in the early stress response of DNA damage, which is involved in DNA damage repair and cellular senescence. Olaparib, as PARP inhibitor, has an anti-tumor effect on high grade serous ovarian cancer, but its effects on cellular senescence have not been reported. This study intends to explore the role of olaparib in the regulation of senescence in ovarian cancer cells.
    Methods: The effects of olaparib on the senescence of ovarian cancer cells were detected by using the senescence-associated beta-galactosidase (SA-beta-Gal) and senescence-associated heterochromatin aggregation (SAHF). Quantitative real-time polymerase chain reaction was used to analyze the senescence-associated secretory phenotype (SASP). Cell cycle and apoptosis were detected by flow cytometry. The effect of olaparib on tumor growth was analyzed in a nude mouse xenograft transplantation model.
    Results: Long-term (6 days) treatment with olaparib (5 mu M) significantly inhibited the growth of ovarian cancer cells, leading to arrest the cell cycle at G0/G1 phase, significant increase the number of positive SA-beta-Gal stained cells and positive SAHF cells. The expression of P16 and retinoblastoma protein (p-RB) were significantly enhanced in SKOV3 cells under olaparib treated, meanwhile, the expression of P53 and p-RB were upregulated in A2780 cells. In OVCAR-3 cells, the expression of P53 was downregulated and p-RB was upregulated. Mice with SKOV3 xenograft transplantation was given olaparib (10 mg/kg/day) via abdominal cavity administration, the tumor volume was reduced (p<0.01).
    Conclusion: Continuous low dosage administration of olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.

  • 推荐引用方式
    GB/T 7714:
    Wang Zehua,Gao Jianwen,Zhou Jiabing, et al. Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer [J].JOURNAL OF GYNECOLOGIC ONCOLOGY,2019,30(2).
  • APA:
    Wang Zehua,Gao Jianwen,Zhou Jiabing,Liu Haiou,&Xu Congjian.(2019).Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer .JOURNAL OF GYNECOLOGIC ONCOLOGY,30(2).
  • MLA:
    Wang Zehua, et al. "Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer" .JOURNAL OF GYNECOLOGIC ONCOLOGY 30,2(2019).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:6 下载次数:0
浏览次数:6
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部